For questions about BMS medicines during this time, please
This website is best viewed using the
horizontal display on your tablet device.
This website is best viewed using the
vertical display on your mobile device.
Targeting of normal cells can also occur.2,3
OPDIVO helps existing T cells discover the
tumor by blocking PD-1.4-9
YERVOY helps activate and proliferate T cells by blocking CTLA-4, and also reduces Treg function.1,4,5
Select a patient population below to review trial
results, or view available Bristol Myers Squibb
resources
Checkmate 067 clinical trial
Checkmate 238 clinical trial
Clinical trial presentation
decks, education, and
patient support materials